Drug target · OPRD1

DOR

Delta-type opioid receptor

1 compound in the CNS pipeline acts on DOR.

Compounds targeting DOR

CompoundActionAffinityLead programDeveloper
Navacaprant (NMRA-140)Small moleculeAntagonistIC50 6500 nMDiscontinuedMajor depressive disorderNeumora Therapeutics, Inc.